MedTrace Logo

Guided and Traditional Cognitive Behavioral Therapy Protocol for Resistant Panic

NCT07247955 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2025-11-25

No results posted yet for this study

Summary

Self-guided therapy for anxiety disorders has focused on various cognitive-behavioral treatments mediated by technologies such as web applications. This study aims to compare two groups of patients with panic disorder undergoing two clinical psychological treatment models: one traditional cognitive behavioral therapy (CBT), and the other self-guided CBT using a digital application.

An application was developed in which both treatment models follow the same eight-session CBT manual. Patients are evaluated using psychological assessments at the first and eighth sessions.

The study includes 46 patients divided into two groups of 23 participants each. Both groups undergo individual assessments at the beginning and end of the treatment protocol.

Conditions

  • Panic Disorder

Interventions

BEHAVIORAL

The group intervention used the sessions described in traditional form

Model of the sessions: * Session 1 - General information for the Client * Session 2 - Breaking the panic cycle * Session 3 - Increasing the range of cognitive management skills * Session 4 - Improving corporal management skills * Session 5 - Strengthening self-efficacy * Session 6 - Stimulating life reorientation * Session 7 - Promoting existential management * Session 8 - Revising and evaluating the treatment

BEHAVIORAL

The group intervention used the sessions described in a self-guided format using an application

Model of the sessions: * Session 1 - General information for the Client * Session 2 - Breaking the panic cycle * Session 3 - Increasing the range of cognitive management skills * Session 4 - Improving corporal management skills * Session 5 - Strengthening self-efficacy * Session 6 - Stimulating life reorientation * Session 7 - Promoting existential management * Session 8 - Revising and evaluating the treatment

Sponsors & Collaborators

  • Universidade Federal do Rio de Janeiro

    lead OTHER

Principal Investigators

  • Luisa Pelucio, Master · Universidade Federal do Rio de Janeiro

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-05
Primary Completion
2024-10-15
Completion
2025-05-02

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07247955 on ClinicalTrials.gov